Trials / Terminated
TerminatedNCT01760161
Bilateral Dual Transversus Abdominis Plane Block for Robotic Assisted Laparoscopic Surgery
A Randomised, Double-blind Study to Evaluate the Effect of Bilateral Dual Transversus Abdominis Plane Block on Postoperative Pain and Plasma Concentration of Ropivacaine After Robotic Assisted Laparoscopic Surgery
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Aalborg University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effects of bilateral dual transversus abdominis plane block on postoperative pain after robotic assited laparoskopic surgery and measure the plasma-level of ropivacain after the bilateral dual transversus abdominis plane block.
Detailed description
After randomisation patients for robotic assisted laparoscopic surgery will receive bilateral dual transversus abdominis plane block containing either ropivacain or isotonic potassium chloride. The investigators will record pain-score, opioid-consumption and sensibility on the abdominal wall in the postoperative periode. Also a blood sample will be taken at 15, 30, 60, 120 and 240 minutes after the block in order to measure the plasma-level of ropivacain after bilateral dual transversus abdominis plane block. The investigators assume that there will be significant effect on postoperative pain and that the level of plasma-ropivacain will be acceptable.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | Ropicacain 3,75 mg/ml 15 ml x 4 when placing the Bilateral Dual Transverus Abdominis Plane block |
| DRUG | Isotonic potassium chloride | Isotonic potassium chloride 15 ml x 4 when placing the bilateral dual transverus abdominis plane block. |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-12-01
- Completion
- 2016-02-01
- First posted
- 2013-01-04
- Last updated
- 2015-05-12
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01760161. Inclusion in this directory is not an endorsement.